Fig. 2From: MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathwayRelative MYO18B expression in hepatocellular carcinoma cells. a The expression levels of MYO18B in HepG2 and HL-7702 cell lines were analyzed by qRT-PCR. MYO18B expression displayed a higher level in HepG2 cells. b-d HepG2 cells were transfected with one specific siRNA (experimental group, si-MYO18B) or non-specific control siRNA (negative control group, si-con). MYO18B expression was determined by qRT-PCR (b) and western blot (c, d) respectively. *P < 0.05 versus si-con groupBack to article page